196 related articles for article (PubMed ID: 27712770)
1. From "Samter's Triad" to "NERD": The Long and Winding Road to Understanding Aspirin-Exacerbated Respiratory Disease.
Tilles SA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):xiii-xiv. PubMed ID: 27712770
[No Abstract] [Full Text] [Related]
2. Aspirin-Exacerbated Respiratory Disease: The Hunt for the "Rosetta Stone" of Respiratory Inflammation.
White AA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):xv-xvi. PubMed ID: 27712771
[No Abstract] [Full Text] [Related]
3. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
Park H; Choi Y; Jung CG; Park HS
Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
[TBL] [Abstract][Full Text] [Related]
4. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease.
Steinke JW; Negri J; Liu L; Payne SC; Borish L
J Immunol; 2014 Jul; 193(1):41-7. PubMed ID: 24890720
[TBL] [Abstract][Full Text] [Related]
5. Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease.
Cahill KN
J Allergy Clin Immunol; 2021 Aug; 148(2):344-347. PubMed ID: 34144108
[No Abstract] [Full Text] [Related]
6. Samter's triad in childhood: a warning for those prescribing NSAIDs.
Ameratunga R; Randall N; Dalziel S; Anderson BJ
Paediatr Anaesth; 2013 Aug; 23(8):757-9. PubMed ID: 23782034
[TBL] [Abstract][Full Text] [Related]
7. Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab.
Phillips-Angles E; Barranco P; Lluch-Bernal M; Dominguez-Ortega J; López-Carrasco V; Quirce S
J Allergy Clin Immunol Pract; 2017; 5(3):842-845. PubMed ID: 28117272
[No Abstract] [Full Text] [Related]
8. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
9. Update on Aspirin-Exacerbated Respiratory Disease.
Woessner KM
Curr Allergy Asthma Rep; 2017 Jan; 17(1):2. PubMed ID: 28097500
[TBL] [Abstract][Full Text] [Related]
10. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
[No Abstract] [Full Text] [Related]
11. A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.
Cameli P; D'Alessandro M; Bergantini L; Silvestri E; Romaldi A; Emmi G; Parronchi P; Bargagli E
Monaldi Arch Chest Dis; 2020 Aug; 90(3):. PubMed ID: 32885934
[TBL] [Abstract][Full Text] [Related]
12. Aspirin sensitivity does not compromise quality-of-life outcomes in patients with Samter's triad.
Jang DW; Comer BT; Lachanas VA; Kountakis SE
Laryngoscope; 2014 Jan; 124(1):34-7. PubMed ID: 23712910
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and NSAID sensitivity.
Stevenson DD
Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
[TBL] [Abstract][Full Text] [Related]
14. Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis.
White AA; Doherty TA
Am J Rhinol Allergy; 2018 Jan; 32(1):7-11. PubMed ID: 29336282
[TBL] [Abstract][Full Text] [Related]
15. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
Krouse HJ; Krouse JH
ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease.
Bochenek G; Szafraniec K; Kuschill-Dziurda J; Nizankowska-Mogilnicka E
Respir Med; 2015 May; 109(5):588-95. PubMed ID: 25820158
[TBL] [Abstract][Full Text] [Related]
17. Platelets in patients with aspirin-exacerbated respiratory disease.
Laidlaw TM; Boyce JA
J Allergy Clin Immunol; 2015 Jun; 135(6):1407-14; quiz 1415. PubMed ID: 26051947
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab treatment in Samter's triad: case series and review of the literature.
Cameli P; Perruzza M; Salvini M; Fui A; Cekorja B; Refini RM; Sestini P; Bargagli E
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8124-8129. PubMed ID: 31599440
[TBL] [Abstract][Full Text] [Related]
19. New insights on the possible role of mast cells in aspirin-induced asthma.
Mortaz E; Engels F; Nijkamp FP; Redegeld FA
Curr Mol Pharmacol; 2009 Jun; 2(2):182-9. PubMed ID: 20021457
[TBL] [Abstract][Full Text] [Related]
20. [Aspirin-induced asthma (AIA)].
Sakakibara H; Yoneda Y
Nihon Rinsho; 2005 May; 63 Suppl 5():114-9. PubMed ID: 15954335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
